Abstract:The BMI1 protein contributes to stem cell pluripotency and oncogenesis via multiple functions, including its newly identified role in DNA damage response (DDR). Although evidence clearly demonstrates that BMI1 facilitates the repair of double-stranded breaks via homologous recombination (HR), it remains unclear how BMI1 regulates checkpoint activation during DDR. We report here that BMI1 has a role in G2/M checkpoint activation in response to etoposide (ETOP) treatment. Ectopic expression of BMI1 in MCF7 breast cancer and DU145 prostate cancer cells significantly reduced ETOP-induced G2/M arrest. Conversely, knockdown of BMI1 in both lines enhanced the arrest. Consistent with ETOP-induced activation of the G2/M checkpoints via the ATM pathway, overexpression and knockdown of BMI1, respectively, reduced and enhanced ETOP-induced phosphorylation of ATM at serine 1981 (ATM pS1981). Furthermore, the phosphorylation of ATM targets, including γH2AX, threonine 68 (T68) on CHK2 (CHK2 pT68) and serine 15 (S15) on p53 were decreased in overexpression and increased in knockdown BMI1 cells in response to ETOP. In line with the requirement of NBS1 in ATM activation, we were able to show that BMI1 associates with NBS1 and that this interaction altered the binding of NBS1 with ATM. BMI1 consists of a ring finger (RF), helix-turn-helix-turn-helix-turn (HT), proline/serine (PS) domain and two nuclear localization signals (NLS). Although deletion of either RF or HT did not affect the association of BMI1 with NBS1, the individual deletions of PS and one NLS (KRMK) robustly reduced the interaction. Stable expression of these BMI1 mutants decreased ETOP-induced ATM pS1981 and CHK2 pT68, but not ETOP-elicited γH2AX in MCF7 cells. Furthermore, ectopic expression of BMI1 in non-transformed breast epithelial MCF10A cells also compromised ETOP-initiated ATM pS1981 and γH2AX. Taken together, we provide compelling evidence that BMI1 decreases ETOP-induced G2/M checkpoint activation via reducing NBS1-mediated ATM activation.

WSB1 Overcomes Oncogene-Induced Senescence by Targeting ATM for Degradation

WSB1 Promotes Tumor Metastasis by Inducing Pvhl Degradation

Hypoxia-Induced Wsb1 Promotes the Metastatic Potential of Osteosarcoma Cells

BMI1 Attenuates Etoposide-Induced G2/M Checkpoints Via Reducing ATM Activation.

Alternative Wnt-signaling axis leads to a break of oncogene-induced senescence

Elevated expression of WSB2 degrades p53 and activates the IGFBP3-AKT-mTOR-dependent pathway to drive hepatocellular carcinoma

DNA Damage Checkpoint Recovery and Cancer Development

Emerging roles of the p38 MAPK and PI3K/AKT/mTOR pathways in oncogene-induced senescence

ATM-mediated Stabilization of ZEB1 Promotes DNA Damage Response and Radioresistance Through CHK1.

Abstract 1638: Hypoxia-induced WSB1 Promotes the Metastatic Potential of Osteosarcoma Cells

Oncogene-induced senescence mediated by c-Myc requires USP10 dependent deubiquitination and stabilization of p14ARF

Disruption of WSB2-mediated NOXA Degradation Induces Synthetic Lethality to Anti-apoptotic BCL-2 Family Protein Inhibitors

The type 2C phosphatase Wip1: An oncogenic regulator of tumor suppressor and DNA damage response pathways

Oncogene-induced senescence: From biology to therapy

WSB1 Regulates C-Myc Expression Through Β-Catenin Signaling and Forms a Feedforward Circuit Promoting the Development of Cancer

Oncogene-induced senescence: a potential breakpoint mechanism against malignant transformation in plasma cell disorders

Knockdown of WWP1 Inhibits Growth and Invasion, but Induces Apoptosis of Osteosarcoma Cells.

Wip1 suppresses ovarian cancer metastasis through the ATM/AKT/Snail mediated signaling.

USP1-WDR48 deubiquitinase complex enhances TGF-β induced epithelial–mesenchymal transition of TNBC cells via stabilizing TAK1

Reversal of the ATM/ATR-mediated DNA Damage Response by the Oncogenic Phosphatase PPM1D.

WSB1 Regulates C-Myc Expression Through Β-Catenin Signaling and Forms a Feedforward Circuit